Clinical Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery

NACompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

September 4, 2017

Primary Completion Date

November 17, 2021

Study Completion Date

December 17, 2021

Conditions
Femur Fracture
Interventions
DIAGNOSTIC_TEST

Platelet function assay

"Plateletworks is an in vitro diagnostic screening assay for the determination of % platelet aggregation or % platelet inhibition.~It will be used to measure platelet function after withdrawal of the antiplatelet agent.~If there are more than 80,000 functional platelets, the patient will be operated on within the next 24 hours."

Trial Locations (3)

Unknown

Althaia, Xarxa Assistencial Universitària de Manresa, Manresa

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Vall d'Hebron, Barcelona

All Listed Sponsors
collaborator

Carlos III Health Institute

OTHER_GOV

collaborator

Spanish Clinical Research Network - SCReN

NETWORK

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT03231787 - Clinical Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery | Biotech Hunter | Biotech Hunter